On February 13, 2026, investment firm Affinity Asset Advisors made a significant commitment to praxis Precision Medicines, acquiring 185,000 shares in a transaction valued at approximately $54.53 million. This strategic move came during the fourth quarter and now represents 3.11% of the fund's 13F r